Press release
Dyslipidemia - Pipeline Review, H1 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dyslipidemia - Pipeline Review, H1 2017, provides an overview of the Dyslipidemia (Metabolic Disorders) pipeline landscape.
Dyslipidemia is defined as elevation of the total cholesterol, the ""bad"" low-density lipoprotein (LDL) cholesterol and the triglyceride concentrations, and a decrease in the ""good"" high-density lipoprotein (HDL) cholesterol concentration in the blood. Numerous factors and causes can lead to an abnormality in the levels of lipids in the blood such as genetic predisposition, diet, age and gender, type II diabetes. Common symptoms that may be encountered in relation to dyslipidemia include corneal opacification, corneal arcus, xanthomas, balance impairment, pain in the calf when walking, dizziness and confusion.
To Enquire about this Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=15329
Scope of the Research Report
- The pipeline guide provides a snapshot of the global therapeutic landscape of Nasal Polyposis (Ear Nose Throat Disorders).
- The pipeline guide reviews pipeline therapeutics for Nasal Polyposis (Ear Nose Throat Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Nasal Polyposis (Ear Nose Throat Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Nasal Polyposis (Ear Nose Throat Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Nasal Polyposis (Ear Nose Throat Disorders)
To view a detailed description and Table of Contents please visit: https://www.reportsworldwide.com/report/dyslipidemia-pipeline-review-h1-2017
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Nasal Polyposis (Ear Nose Throat Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Nasal Polyposis (Ear Nose Throat Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
About ReportsWorldwide.com
ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.
Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-4994
Fax +1 (617) 398-4995
abigail@reportsworldwide.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dyslipidemia - Pipeline Review, H1 2017 here
News-ID: 574888 • Views: …
More Releases from ReportsWorldwide
World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence…
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA
ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports.
Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors.
Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that…
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA
ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports.
This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers:
• CommScope/Airvana
• Comba Telecom
• Ericsson
• Huawei Technologies
• Nokia
• SpiderCloud
• ZTE Corporation
This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021.
To view a detailed description and Table of…
More Releases for Disorders
Bleeding Disorders Market Is Driven By Bleeding Disorders In Various Industries, …
The Bleeding Disorders Market is a critical component of the healthcare industry, focused on the diagnosis, treatment, and management of bleeding disorders that affect individuals' blood clotting mechanisms. These disorders, which include hemophilia, von Willebrand disease, and various clotting factor deficiencies, can lead to prolonged and spontaneous bleeding, posing significant health risks. This market encompasses a range of therapies, medications, and diagnostic tools designed to address the unique needs of…
Gene Therapy For Rare Disease Market By Therapeutic Application ( Oncology, Neur …
The Gene Therapy For Rare Disease Market report outlines the evolution of Gene Therapy For Rare Disease industry by type, applications and identifies and assesses the best performing vendors in the market till 2028. Gene Therapy For Rare Disease Market reports present the revenue opportunities in the Gene Therapy For Rare Disease industry through 2023-2028, highlighting the market size and growth by technology, geography, vertical and End users.
Download Sample PDF…
Neuroprosthetics Market 2019 Industry Segmentation by physiological disorders ar …
Neuroprosthetics Market 2019 Scenario
Neuroprosthetics Market was estimated to be USD 5.28 billion in 2016 and expected to reach USD 10.48 billion by 2023. The key factors responsible for driving this are increasing in geriatric population, auditory processing disorders in kids, and increase in spinal cord treatment due to advancement in neuroprosthetics devices.
The factors responsible for the positive growth of this market are increasing prevalence of neural diseases, over active bladder…
Global Vocal Biomarker Market to Experience Significant Growth during the Foreca …
Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known as Vocal Biomarker Market by combining the concept of biological markers with the aforementioned methodology to analyze personality traits.
Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=719
These vocal biomarkers are…
Behavioral Therapy Market Report 2018: Segmentation by Type (Anxiety Disorders, …
Global Behavioral Therapy market research report provides company profile for American Addiction Centers, ChanceLight, Haven Behavioral Healthcare, Behavioral Health Group, Center for Autism & Related Disorders, People’s Care, Magellan Health, Universal Health Services, Acadia Healthcare, Springstone and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…
Biopharmaceuticals Market Outlook 2025|( Biopharmaceuticals Application:- Infect …
Global Biopharmaceuticals Market Research Report Brief Focus On Study About Biopharmaceuticals Market Industry volume, Market Revenue, Market Segments , Market Trends ,Growth aspects A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report such as:
Biopharmaceuticals Product Type:- Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines,
Biopharmaceuticals Application :- Inflammatory , Infectious Diseases, Autoimmune Disorders, Metabolic…
